Source link : https://www.mondialnews.com/2026/04/12/inside-big-pharmas-secretive-clinical-trials-in-china-what-you-need-to-know/
As the global pharmaceutical industry increasingly turns to China for clinical trials, concerns are mounting over the lack of transparency and regulatory oversight surrounding these studies. Investigations reveal that many trials conducted by major multinational drug companies in China are escaping rigorous scrutiny, raising questions about data integrity and patient safety. This spotlight on China’s clinical research landscape exposes gaps that could have far-reaching implications for drug approval processes worldwide. In this article, The Wire China delves into how Big Pharma’s China-based trials are operating under the radar and what this means for the future of global healthcare regulation.
China’s Regulatory Gaps Allow Big Pharma Trials to Operate Under the Radar
Despite China’s rapid ascent as a global hub for pharmaceutical research, significant regulatory gaps continue to allow major pharmaceutical companies to conduct clinical trials with minimal oversight. These loopholes often result in critical data and trial practices remaining obscured from public and governmental scrutiny. The lack of stringent auditing mechanisms combined with ambiguous reporting requirements enables foreign and domestic firms alike to sidestep transparency, raising concerns about patient safety and data integrity. Particularly troubling is the uneven enforcement of existing laws across provinces, where some local authorities prioritize economic incentives over rigorous…
—-
Author : Samuel Brown
Publish date : 2026-04-12 22:40:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8